Value through Innovation27 July 2016

What is a lay summary?

To view this video in other translations click on the language below:
Chinese (simplified)
Chinese (traditional)
French
German
Italian
Japanese
Portuguese (Brazilian)
Spanish

Lay Summaries and Lay Summary Videos

  • BI 443651 - Asthma
    Clinical Study Number 1363.7
    Study Indication Asthma
    Product BI 443651
    Generic Name BI 443651
    Lab Code BI 443651
    Clinical Phase I
    Study Title

    A 2-part phase I, multiple-dose, single- and double-blind randomised, doubledummy, placebo-controlled, 4-way crossover study to assess safety and tolerability of BI 443651 via Respimat® versus placebo via Respimat® in subjects with mild asthma following methacholine challenge

    Study Document
    Lay summary 1363.7 english
  • BI 443651 - Cystic Fibrosis , Healthy
    Clinical Study Number 1363.2
    Study Indication Cystic Fibrosis ; Healthy
    Product BI 443651
    Generic Name BI 443651
    Lab Code BI 443651
    Clinical Phase Ib
    Study Title

    A Phase Ib, multicentre, double blind, randomised, two-part study, first part multiple rising dose and second part two-way cross-over, to assess safety, tolerability, efficacy and pharmacokinetics of BI 443651 compared to placebo via Respimat® in healthy volunteers and cystic fibrosis subjects

    Study Document
    Lay summary 1363.2 english
    Lay summary 1363.2 german